Article

FDA study finds Visian ICL offers good long-term BSCVA

Over a five-year follow-up period the Visian implantable collamer lens (ICL) (STAAR Surgical) maintains a good level of best spectacle corrected visual acuity (BSCVA).

Over a five-year follow-up period the Visian implantable collamer lens (ICL) (STAAR Surgical) maintains a good level of best spectacle corrected visual acuity (BSCVA), according to results from the US multicentre FDA study, as reported by John Vukich of Madison, Wisconsin, USA.

A total of 248 patients implanted with the Visian ICL have been followed for four yeas and 335 have been followed for >5 years. The average preoperative myopia was -10.06 D.

At five years, 52.7% of eyes with a preoperative BSCVA of 20/20 or better achieved a UCVA of 20/20 or better and 91.2% achieved a UCVA of 20/40 or better. Over the five-year period, seven patients (1.3%) developed clinically significant anterior subcapsular cataracts, each requiring extraction. No other complications were reported.

The results of this FDA study indicate that the Visian ICL is safe and effective in maintaining BSCVA over a five-year period.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.